Leiomyosarcoma
Showing 1 - 25 of 313
Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)
Recruiting
- Leiomyosarcoma
-
Los Angeles, CaliforniaSarcoma Oncology Center
Oct 16, 2023
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Recruiting
- Locally Advanced Leiomyosarcoma
- +5 more
- Olaparib
- +3 more
-
New York, New YorkColumbia University/Herbert Irving Cancer Center
Jan 4, 2023
People With Leiomyosarcoma
Not yet recruiting
- Leiomyosarcoma
- (no location specified)
Sep 16, 2022
Metastatic Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Plasma Collection
-
Rochester, Minnesota
- +2 more
Jan 5, 2023
Localized Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Blood and Tissue collection
-
Ann Arbor, Michigan
- +3 more
Jan 5, 2023
Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)
Recruiting
- Leiomyosarcoma
- Liposarcoma
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022
LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)
Suspended
- LMS - Leiomyosarcoma
- Uterine Leiomyosarcoma
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University
Oct 24, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)
Not yet recruiting
- Soft Tissue Sarcoma
- ADI PEG20
- Placebo
- (no location specified)
Jan 31, 2023
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +6 more
- Niraparib Tosylate Monohydrate
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 25, 2022
Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)
Active, not recruiting
- Leiomyosarcoma
- +3 more
-
Taipei, Taiwan
- +1 more
Dec 27, 2022
Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory
Active, not recruiting
- Metastatic Leiomyosarcoma
- +2 more
- Ipilimumab
- +2 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)
Recruiting
- Leiomyosarcoma
- Dinutuximab Beta, Zoledronic acid, Interleukin-2
-
Bad Saarow, Germany
- +1 more
Jun 2, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,
Recruiting
- Advanced Soft-tissue Sarcoma
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 14, 2022
Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)
Recruiting
- Leiomyosarcoma
- Temozolomide for injection combined with epirubicin
-
Beijing, Beijing, ChinaCancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022
Leiomyosarcoma Trial in Toulouse (Blood samples will be collected at different times.)
Not yet recruiting
- Leiomyosarcoma
- Blood samples will be collected at different times.
-
Toulouse, FranceInstitut Universitaire du Cancer Toulouse - Oncopole
Aug 2, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)
Completed
- Uterine or Soft Tissue Leiomyosarcoma
-
Villejuif, Val De Marne, FranceGustave Roussy
Dec 10, 2021
Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United
Recruiting
- Metastatic Leiomyosarcoma
- +10 more
- Cabozantinib
- +3 more
-
Duarte, California
- +4 more
Nov 4, 2021
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022